Answers are grounded in this paper and cite their sources.
Camelid single-domain antibody ciA-B5 demonstrates specificity for BoNT/A light chain, highlighting its potential applications in diagnostics.
Camelid single-domain antibody (VHH) ciA-B5 detects by ELISA the light chain (LC) of the botulinum neurotoxin type A (BoNT/A).
No takes yet. Share an insight, caveat, or question.
Pham et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: